Thursday, 20 July 2023

Volatile Organic Compound Emission from Human Skin in Health and Disease | Chapter 11 | Current Progress in Medicine and Medical Research Vol. 2

 The aim concerning this chapter search out examine the serviceableness of volatile natural compound (VOC) emissions came from the human skin in the context of human strength and disease. The reasoning of volatile basic compounds (VOCs) emitted from the human material can provide personalised news about underlying metabolic pathophysiological processes completely non- invasively. Despite the skin being the second largest subscriber to the production of VOCs, it is an underexplored arm of the overall human volatolome and consequently the part of human skin to VOC production and the exact range to which skin VOCs maybe signatures of fitness and disease is obscure.This chapter investigate the role of skin VOCs in the more extensive scientific and dispassionate context of the whole human volatolome. First, the literature countryside of the human volatolome and its dispassionate applications is characterized. The focus of this unit then shifts to the human skin volatolome. Key concerning details processes and challenges in skin VOC capture and analysis are thought-out. This is followed by a inclusive summary and literature judgment of research on skin VOCs in health and affliction with a singular perspective on illuminating the biological inceptions of skin VOCs aiming to link the phenotype to the fundamental disease process.Finally, the phase concludes by debating the current limitations of skin VOC research and desires future research directions in this place novel scientific field that can strengthen the dispassionate translational value of skin VOCs.

Author(s) Details:

Anuja T. Mitra,

Department of Surgery and Cancer, Imperial College London, St Mary’s Hospital, Paddington, London, W21NY, United Kingdom.

Alexandra Razumovskaya-Hough,

Department of Surgery and Cancer, Imperial College London, St Mary’s Hospital, Paddington, London, W21NY, United Kingdom.

George B. Hanna,

Department of Surgery and Cancer, Imperial College London, St Mary’s Hospital, Paddington, London, W21NY, United Kingdom.

Please see the link here: https://stm.bookpi.org/CPMMR-V2/article/view/11291

No comments:

Post a Comment